BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8817423)

  • 1. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low birth weight infants--mortality and predictive risk factors.
    Chye JK; Lim CT
    Singapore Med J; 1999 Sep; 40(9):565-70. PubMed ID: 10628243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997.
    Stoelhorst GM; Rijken M; Martens SE; Brand R; den Ouden AL; Wit JM; Veen S;
    Pediatrics; 2005 Feb; 115(2):396-405. PubMed ID: 15689337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Administration of exogenous surfactant in premature very low birth weight infants with RDS].
    Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A
    Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants.
    Sharma P; McKay K; Rosenkrantz TS; Hussain N
    BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial of the use of the Russian surfactant Surfactant HL for treating the respiratory distress syndrome in newborn infants].
    Grebennikov VA; Everstova TN; Safonov IV
    Anesteziol Reanimatol; 1998; (4):36-9. PubMed ID: 9770817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants with gestational age 28 weeks or less.
    Holmsgaard KW; Petersen S
    Dan Med Bull; 1996 Feb; 43(1):86-91. PubMed ID: 8906983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should very low birthweight babies best be managed in Papua New Guinea?
    Brown N
    P N G Med J; 1996 Mar; 39(1):12-5. PubMed ID: 9522845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study.
    Nafday SM; Green RS; Lin J; Brion LP; Ochshorn I; Holzman IR
    J Perinatol; 2005 Mar; 25(3):193-7. PubMed ID: 15674409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic surfactant.
    Long W
    Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s.
    Wilson-Costello D; Friedman H; Minich N; Fanaroff AA; Hack M
    Pediatrics; 2005 Apr; 115(4):997-1003. PubMed ID: 15805376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use and efficacy of treatment with porcine surfactant in newborns with birth weight < or = 1000 g: experience in 3 years].
    Brusamento S; Buffo M; Carnielli VP
    Pediatr Med Chir; 1999; 21(6):261-5. PubMed ID: 11293146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.